Masimo Corporation (MASI) Stock Analysis
Healthcare · Medical Devices
Sell if holding. Analyst target reached at $178.35 — A.R:R is negative (-0.9) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Product: Masimo SET and rainbow SET platforms.
Masimo develops noninvasive patient monitoring technologies, hospital automation, and connectivity solutions sold to hospitals globally. After divesting its consumer electronics unit (Sound United) in September 2025, Masimo agreed to be acquired by Danaher at $180/share in a... Read more
Sell if holding. Analyst target reached at $178.35 — A.R:R is negative (-0.9) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Product: Masimo SET and rainbow SET platforms. Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Score 5.4/10, moderate confidence.
Passes 4/7 gates (clean insider activity, no SEC red flags, news events none recent, semi cycle peak clear). Fails on weak momentum and favorable risk/reward ratio and earnings proximity 5d<=7d. Suitability: moderate.
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHProductMasimo SET and rainbow SET platforms10-K Item 1A: 'We currently derive a significant portion of our revenue from our Masimo SET® platform, Masimo rainbow SET® platform and related products.'
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
2 floor-breakers
Momentum below the gate floor. Component breakdown shows what dragged the score down.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Analyst target reached at $178.35 — A.R:R is negative (-0.9) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Product: Masimo SET and rainbow SET platforms. Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Prior stop was $177.85. Score 5.4/10, moderate confidence.
Take-profit target: $175.27 (-1.7% upside). Prior stop was $177.85. Stop-loss: $177.85.
Concentration risk — Product: Masimo SET and rainbow SET platforms; Analyst target reached - limited upside remaining; Near 52-week high (0.4% away).
Masimo Corporation trades at a P/E of 46.5 (forward 27.0). TrendMatrix value score: 4.7/10. Verdict: Sell.
15 analysts cover MASI with a consensus score of 3.5/5. Average price target: $180.
What does Masimo Corporation do?Masimo develops noninvasive patient monitoring technologies, hospital automation, and connectivity solutions sold to...
Masimo develops noninvasive patient monitoring technologies, hospital automation, and connectivity solutions sold to hospitals globally. After divesting its consumer electronics unit (Sound United) in September 2025, Masimo agreed to be acquired by Danaher at $180/share in a deal expected to close second half of 2026.